Trial of Perioperative Tadalafil and Influenza Vaccination in Cancer Patients Undergoing Major Surgical Resection of a Primary Abdominal Malignancy (PERIOP-04)
PERIOP-04 Phase Ib Trial of Perioperative Tadalafil and Influenza Vaccination in Cancer Patients Undergoing Major Surgical Resection of a Primary Abdominal Malignancy
Sponsor: Ottawa Hospital Research Institute
Listed as NCT02998736, this PHASE1 trial focuses on Abdominal Cancer and remains completed. Sponsored by Ottawa Hospital Research Institute, it has been updated 8 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Feb 2023 — Jul 2024 [monthly]
Completed PHASE1
Status: Unknown Status → Completed
-
Jan 2023 — Feb 2023 [monthly]
Unknown Status PHASE1
Status: Recruiting → Unknown Status
-
Jan 2021 — Jan 2023 [monthly]
Recruiting PHASE1
▶ Show 3 earlier versions
-
Apr 2019 — Jan 2021 [monthly]
Recruiting PHASE1
-
Jun 2018 — Apr 2019 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Ottawa Hospital Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .